Suppr超能文献

组织蛋白酶G而非天冬酰胺特异性内蛋白酶,控制人B淋巴细胞溶酶体中髓鞘碱性蛋白的加工过程。

Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.

作者信息

Burster Timo, Beck Alexander, Tolosa Eva, Marin-Esteban Viviana, Rötzschke Olaf, Falk Kirsten, Lautwein Alfred, Reich Michael, Brandenburg Jens, Schwarz Gerold, Wiendl Heinz, Melms Arthur, Lehmann Rainer, Stevanovic Stefan, Kalbacher Hubert, Driessen Christoph

机构信息

Department of Medicine II, University of Tübingen, Tübingen, Germany.

出版信息

J Immunol. 2004 May 1;172(9):5495-503. doi: 10.4049/jimmunol.172.9.5495.

Abstract

The asparagine-specific endoprotease (AEP) controls lysosomal processing of the potential autoantigen myelin basic protein (MBP) by human B lymphoblastoid cells, a feature implicated in the immunopathogenesis of multiple sclerosis. In this study, we demonstrate that freshly isolated human B lymphocytes lack significant AEP activity and that cleavage by AEP is dispensable for proteolytic processing of MBP in this type of cell. Instead, cathepsin (Cat) G, a serine protease that is not endogenously synthesized by B lymphocytes, is internalized from the plasma membrane and present in lysosomes from human B cells where it represents a major functional constituent of the proteolytic machinery. CatG initialized and dominated the destruction of intact MBP by B cell-derived lysosomal extracts, degrading the immunodominant MBP epitope and eliminating both its binding to MHC class II and a MBP-specific T cell response. Degradation of intact MBP by CatG was not restricted to a lysosomal environment, but was also performed by soluble CatG. Thus, the abundant protease CatG might participate in eliminating the immunodominant determinant of MBP. Internalization of exogenous CatG represents a novel mechanism of professional APC to acquire functionally dominant proteolytic activity that complements the panel of endogenous lysosomal enzymes.

摘要

天冬酰胺特异性内肽酶(AEP)控制人B淋巴母细胞对潜在自身抗原髓鞘碱性蛋白(MBP)的溶酶体加工过程,这一特性与多发性硬化症的免疫发病机制有关。在本研究中,我们证明新鲜分离的人B淋巴细胞缺乏显著的AEP活性,并且在这类细胞中,AEP的切割对于MBP的蛋白水解加工并非必需。相反,组织蛋白酶(Cat)G,一种B淋巴细胞不内源性合成的丝氨酸蛋白酶,从质膜内化并存在于人B细胞的溶酶体中,它是蛋白水解机制的主要功能成分。CatG启动并主导B细胞来源的溶酶体提取物对完整MBP的破坏,降解免疫显性MBP表位,并消除其与MHC II类分子的结合以及MBP特异性T细胞反应。CatG对完整MBP的降解并不局限于溶酶体环境,可溶性CatG也能进行降解。因此,丰富的蛋白酶CatG可能参与消除MBP的免疫显性决定簇。外源性CatG的内化代表了专职抗原呈递细胞获得功能上占主导地位的蛋白水解活性的一种新机制,这种机制补充了内源性溶酶体酶的种类。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验